From: Development of a new stroke scale in an emergency setting
Variables | Â | Univariate regression | Multivariate regression | ||
---|---|---|---|---|---|
N (%) | OR (95 % CI) | P | OR (95 % CI) | P | |
Female | 169 (40.6) | 1 | Â | Â | Â |
Male | 247 (59.4) | 0.81 (0.45–1.43) | 0.461 |  |  |
Age |  | 0.99 (0.97–1.01) | 0.457 |  |  |
GCS > 8 | 353 (84.9) | 1 |  |  |  |
GCS ≤ 8 | 63 (15.1) | 5.75 (1.37–24.20) | 0.017* | 5.70 (1.26–25.80) | 0.024* |
Seizure activity | |||||
 NO | 389 (93.5) | 1 |  |  |  |
 YES | 27 (6.5) | 0.54 (0.21–0.54) | 0.205 |  |  |
Vertigo | |||||
 NO | 371 (89.1) | 1 |  |  |  |
 YES | 45 (10.8) | 0.16 (0.08–0.32) | <0.001* | 0.34 (0.15–0.74) | 0.007* |
Asymmetric facial weakness | |||||
 NO | 227 (54.6) | 1 |  |  |  |
 YES | 189 (45.4) | 6.39 (2.95–13.87) | <0.001* | 2.44 (0.97–6.11) | 0.057 |
Asymmetric arm weakness | |||||
 NO | 192 (46.2) | 1 |  |  |  |
 YES | 224 (53.8) | 11.21 (4.95–25.41) | <0.001* | 3.39 (1.04–11.08) | 0.043* |
Asymmetric leg weakness | |||||
 NO | 179 (43.0) | 1 |  |  |  |
 YES | 237 (57.0) | 9.55 (4.54–20.07) | <0.001* | 2.77 (0.88–8.70) | 0.081 |
Speech disturbance | |||||
 NO | 204 (49.0) | 1 |  |  |  |
 YES | 212 (51.0) | 2.89 (1.58–5.27) | 0.001* | 1.29 (0.58–2.84) | 0.524 |
Visual field defect | |||||
 NO | 347 (83.4) | 1 |  |  |  |
 YES | 69 (16.6) | 13.37 (1.82–98.23) | 0.011* | 3.93 (0.48–32.30) | 0.202 |
Gaze palsy | |||||
 NO | 296 (71.2) | 1 |  |  |  |
 YES | 120 (28.8) | 5.02 (1.95–12.89) | 0.001* | 0.75 (0.19–3.08) | 0.693 |
Pathologic reflex | |||||
 NO | 306 (73.6) | 1 |  |  |  |
 YES | 110 (26.4) | 2.49 (1.14–5.44) | 0.022* | 0.73 (0.28–1.91) | 0.516 |
SBP ≥ 145 mmHg | |||||
 NO | 111 (26.7) | 1 |  |  |  |
 YES | 305 (73.3) | 3.99 (2.25–7.07) | <0.001* | 2.55 (1.25–5.24) | 0.011* |
DBP ≥ 95 mmHg | |||||
 NO | 270 (64.9) | 1 |  |  |  |
 YES | 146 (35.1) | 4.62 (2.04–10.48) | <0.001* | 2.29 (0.87–6.03) | 0.093 |